Evidence map›Paper›PMID 41350950›Full record

ArticleNature structural & molecular biology2026

UBA6 specificity for ubiquitin E2 conjugating enzymes reveals a priority mechanism of BIRC6.

Carlos Riechmann, Cara J Ellison, Jake W Anderson, Kay Hofmann, Peter Sarkies, Paul R Elliott

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carlos RiechmannDepartment of Biochemistry, University of Oxford, Oxford, UK.
Cara J EllisonDepartment of Biochemistry, University of Oxford, Oxford, UK.
Jake W AndersonDepartment of Biochemistry, University of Oxford, Oxford, UK.
Kay HofmannInstitute for Genetics, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-2289-9083
Peter SarkiesDepartment of Biochemistry, University of Oxford, Oxford, UK.
Paul R ElliottDepartment of Biochemistry, University of Oxford, Oxford, UK. paul.elliott@bioch.ox.ac.uk.ORCID http://orcid.org/0000-0002-7641-2103

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In mammals, ubiquitylation is orchestrated by the canonical ubiquitin-activating E1 enzyme UBA1 and the orthogonal E1 UBA6. Growing evidence underscores the essentiality of both E1s, which differentiate between 29 active ubiquitin-conjugating enzymes (E2s). The mechanisms governing this distinction have remained unclear. Here we establish a framework for ubiquitin E1-E2 specificity. Focusing on UBA6-controlled ubiquitylation cascades, we reveal that BIRC6, a UBA6-exclusive E2, gains priority over all other UBA6-competent E2s, underpinning the functional importance of defined UBA6-BIRC6 ubiquitylation events in regulating cell death, embryogenesis and autophagy. By capturing BIRC6 receiving ubiquitin from UBA6 in different states, we observe BIRC6 engaging with the UBA6 ubiquitin fold domain, driving an exceptionally high-affinity interaction that is modulated by the UBA6 Cys-Cap loop. Using this interaction as a template, we demonstrate how to confer activity between E2s and their noncognate E1, providing a tool to delineate E1-E2-dependent pathways. Lastly, we explain how BIRC6 priority does not lead to inhibition of UBA6, through a bespoke thioester switch mechanism that disengages BIRC6 upon receiving ubiquitin. Our findings propose a concept of hierarchy of E2 activity with cognate E1s, which may explain how ubiquitin E1s can each function with over a dozen E2s and orchestrate E2-specific cellular functions.

Indexed as

Inhibitor of Apoptosis ProteinsUbiquitin-Activating EnzymesUbiquitin-Conjugating EnzymesUbiquitinsHumansProtein BindingSubstrate SpecificityUbiquitinationBIRC6 protein, humanInhibitor of Apoptosis ProteinsUBA6 protein, humanUbiquitin-Activating EnzymesUbiquitin-Conjugating EnzymesUbiquitins

Identifiers

PMID41350950
PMCPMC12999496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.